missing translation for 'onlineSavingsMsg'
Learn More
Learn More
IL-7R alpha/CD127 Mouse anti-Rat, Clone: 717519, R&D Systems™
Mouse Monoclonal Antibody
Brand: R&D Systems MAB8484-100

This item is not returnable.
View return policy
Description
IL-7R alpha/CD127 Monoclonal specifically detects IL-7R alpha/CD127 in Rat samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
IL-7R alpha/CD127 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS. | |
CD127, CD127 antigen, CD127ILRA, CDW127, IL-7 R alpha, IL-7 receptor subunit alpha, IL7R, IL7R alpha, IL-7R subunit alpha, IL7RA, IL-7RA, IL-7R-alpha, interleukin 7 receptor, interleukin 7 receptor alpha chain, interleukin 7 receptor isoform H5-6, interleukin-7 receptor subunit alpha | |
Mouse myeloma cell line NS0-derived recombinant rat IL-7 R alpha/CD127 Glu21-Asp239 Accession # NP_001099888 | |
100 μg | |
3575 | |
Reconstitute at 0.5mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
CyTOF, Flow Cytometry | |
717519 | |
Flow Cytometry 0.25μg/106 cells, CyTOF-ready | |
NP_001099888 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
Primary | |
Detects rat IL-7 R alpha/CD127in direct ELISAs. | |
Rat | |
Supernatant |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
IL-7R alpha/CD127 Mouse anti-Rat, Clone: 717519, R&D Systems™
Spot an opportunity for improvement?Share a Content Correction